House Hearing Discusses Children's Medicine Recall

WASHINGTON - MAY 27: Principal Deputy Food and Drug Administration (FDA) Commissioner Joshua Sharfstein (L) and Acting Associate FDA Commissioner for Regulatory Affairs Michael Chappell testify before the House Oversight and Government Reform Committee May 27, 2010 in Washington, DC. The FDA officials testified about the circumstances surrounding the voluntary recall of over 40 over-the-counter variations of infant and children's medicines produced by Johnson & Johnson/McNeil Consumer Healthcare. (Photo by Chip Somodevilla/Getty Images)
WASHINGTON - MAY 27: Principal Deputy Food and Drug Administration (FDA) Commissioner Joshua Sharfstein (L) and Acting Associate FDA Commissioner for Regulatory Affairs Michael Chappell testify before the House Oversight and Government Reform Committee May 27, 2010 in Washington, DC. The FDA officials testified about the circumstances surrounding the voluntary recall of over 40 over-the-counter variations of infant and children's medicines produced by Johnson & Johnson/McNeil Consumer Healthcare. (Photo by Chip Somodevilla/Getty Images)
House Hearing Discusses Children's Medicine Recall
PURCHASE A LICENCE
How can I use this image?
$650.00
NZD

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses. Full editorial rights UK, US, Ireland, Canada (not Quebec). Restricted editorial rights for daily newspapers elsewhere, please call.
Credit:
Editorial #:
101011506
Collection:
Getty Images News
Date created:
27 May, 2010
Upload date:
Licence type:
Release info:
Not released. More information
Source:
Getty Images North America
Object name:
60577290
Max file size:
3000 x 2000 px (25.40 x 16.93 cm) - 300 dpi - 1 MB